Medical Net,Inc. (3645) AI Stock Analysis

• Market Cap: ¥2.83B
• Dividend Yield: 0.93%
• Average Volume (3M): 23.17K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.57
• Revenue Growth: 15.64%
• EPS Growth: -1211.95%
• Country: JP
• Employees: 289
• Sector: Communication Services
• Sector Strength: 96
• Industry: Internet Content & Information
• EPS (TTM): 8.53
• Shares Outstanding: 10,773,000
• 10 Day Avg. Volume: 28,870
• 30 Day Avg. Volume: 23,170
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥332.00
• Price Target Upside: 3.43% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 51 Neutral
• Price Target: ¥332.00 ▲(3.43% Upside)

The overall stock score is primarily impacted by the company's weak financial performance, particularly in profitability and cash flow management. Despite strong technical indicators suggesting bullish momentum, the overbought conditions and negative valuation metrics, such as the negative P/E ratio, present significant risks. The absence of earnings call data and corporate events limits additional insights.

Medical Net,Inc. Business Overview & Revenue Model

Company Description

Medical Net, Inc. (3645) is a healthcare technology company specializing in the development and deployment of innovative medical software solutions. The company operates primarily in the health information technology sector, providing products and services that enhance the efficiency and effectiveness of healthcare delivery. Its core offerings include electronic health record (EHR) systems, telemedicine platforms, and data analytics tools designed to improve patient outcomes and streamline operations for healthcare providers.

How the Company Makes Money

Medical Net, Inc. generates revenue through multiple streams, including the sale of software licenses, subscription fees for its cloud-based services, and transaction fees from telemedicine consultations. The company also partners with hospitals and healthcare organizations to implement its solutions, often resulting in long-term contracts that provide a stable income. Additionally, Medical Net may earn revenue from consulting services related to system integration and ongoing technical support, further enhancing its financial performance.

Medical Net,Inc. Financial Statement Overview

Summary

Medical Net, Inc. faces significant financial challenges, particularly in profitability and cash flow management. While revenue growth is positive, the company's ability to convert this into profit and cash flow is lacking. The balance sheet remains moderately leveraged, but declining profitability and negative cash flows pose risks to financial stability.

Income Statement

The company has experienced moderate revenue growth, but profitability metrics have deteriorated significantly. The gross profit margin has decreased, and the net profit margin turned negative in the latest year, indicating challenges in maintaining profitability. EBIT and EBITDA margins have also declined, reflecting operational inefficiencies.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, which has increased over the years, indicating rising leverage. The return on equity has dropped significantly, reflecting reduced profitability. However, the equity ratio remains stable, suggesting a balanced asset structure.

Cash Flow

The cash flow situation is concerning, with negative operating and free cash flows in the latest year. The free cash flow growth rate is negative, and the ratios of cash flow to net income indicate inefficiencies in cash generation relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.02B	6.07B	5.25B	4.50B	3.75B	2.90B
Gross Profit	1.99B	1.96B	1.84B	1.78B	1.46B	1.18B
EBITDA	13.38M	113.35M	213.29M	315.84M	570.81M	280.84M
Net Income	-186.20M	-68.15M	5.96M	116.18M	380.10M	129.67M
Balance Sheet
Total Assets	4.13B	4.08B	3.99B	3.47B	3.15B	2.11B
Cash, Cash Equivalents and Short-Term Investments	1.40B	1.46B	1.53B	1.52B	1.13B	868.66M
Total Debt	1.35B	1.25B	1.03B	790.83M	773.54M	383.31M
Total Liabilities	2.42B	2.31B	2.06B	1.54B	1.42B	846.98M
Stockholders Equity	1.66B	1.72B	1.91B	1.92B	1.70B	1.24B
Cash Flow
Free Cash Flow	0.00	-212.40M	86.79M	408.50M	340.39M	378.84M
Operating Cash Flow	0.00	-80.86M	119.59M	429.13M	342.55M	391.87M
Investing Cash Flow	0.00	-259.73M	-285.40M	-62.37M	-355.11M	-87.99M
Financing Cash Flow	0.00	219.18M	144.11M	-17.90M	282.23M	-34.03M

Medical Net,Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 321.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3645, the sentiment is Positive. The current price of 321 is above the 20-day moving average (MA) of 319.00, above the 50-day MA of 311.64, and above the 200-day MA of 312.83, indicating a bullish trend. The MACD of 4.13 indicates Positive momentum. The RSI at 54.27 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3645.

Medical Net,Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	$46.60B	4.09	-11.41%	4.12%	1.85%	-42.71%
3845	58 Neutral	¥4.78B	―		―	-26.88%	26.91%
3691	54 Neutral	¥6.10B	3,633.15		―	8.29%	26.77%
3985	54 Neutral	¥3.32B	―		―	-2.64%	-79.22%
3645	51 Neutral	¥2.83B	―		0.93%	15.64%	-1211.95%
2459	51 Neutral	¥1.97B	―		―	-38.66%	16.87%
6081	49 Neutral	¥3.27B	―		―	-14.72%	-60.34%